Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Apr 02, 2026
Blaize Holdings (BZAI): +72% Surge in 30 Days Amid Earnings Strength and AI Edge Momentum

Blaize Holdings (BZAI): +72% Surge in 30 Days Amid Earnings Strength and AI Edge Momentum

Key Takeaways

  • BZAI stock surged +72% over the last 30 days, driven primarily by strong Q4 2025 earnings that beat revenue expectations and positive 2026 guidance.
  • Over the past quarter, the stock declined -12%, reflecting broader market volatility and sector pressures amid ongoing losses despite revenue growth.
  • Key catalysts include earnings beats, partnerships with Nokia and others, and expanding AI edge computing demand in defense, smart cities, and industrial sectors.
  • Revenue grew 20x in 2025 to $38.6 million, highlighting commercial momentum in AI inference infrastructure.
  • Analyst price targets adjusted post-earnings, with focus on path to profitability amid high growth forecasts.

Understanding Blaize Holdings (BZAI) and Its Place in the Market

Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.

In the competitive landscape of semiconductors and AI software, BZAI carves out a niche in edge computing, prioritizing low-power, high-efficiency AI inference for uses like computer vision and video analytics. From what I see, its fundamentals—rapid revenue scaling alongside persistent net losses—capture the recent stock dynamics: enthusiasm for AI demand growth tempers profitability concerns, leading to volatility around earnings and partnerships.

BZAI Stock Performance: 30-Day Rally Versus Quarterly Dip

In the last 30 days, BZAI stock climbed from a closing price of around $1.06 to $1.82, delivering a +72% gain. The path was volatile and trend-driven, hitting a low near $1.00 in early March before surging after Q4 earnings on March 24, with multi-day gains over 15% on elevated volume.

Looking at the past quarter, the stock fell -12%, from about $2.07 in early January to $1.82. It traded in a range, dipping to $1.00 and spiking above $2.00, shaped by sector trends and pre-earnings anticipation, with average daily volume of 5-6 million shares.

Key Drivers Behind BZAI's Recent 30-Day Surge

The main trigger was Blaize's Q4 2025 earnings on March 24, which showed $23.8 million in revenue—beating estimates by $1.8 million and topping guidance—plus full-year revenue of $38.6 million, up 20x year-over-year. The EPS loss narrowed to -$0.03, beating expectations. This sparked a post-earnings rally, with shares up over 40% in following sessions on volume exceeding 6 million shares.

Further support came from strategic moves, such as deeper collaboration with Nokia on edge AI solutions at GITEX Asia and an MOU with GSiL for "Physical AI" safety tech in industrial applications. These bolstered sentiment around commercial growth in Asia-Pacific and sovereign AI. I also checked this using Tickeron’s AI Screener to gauge how BZAI stacks up against industry peers. Post-earnings, analysts tweaked targets down slightly to $5.80 on moderated 2026 revenue outlooks but kept positive coverage, aiding the uptrend.

Factors Shaping BZAI's Quarterly Performance

The -12% quarterly drop reflected AI sector volatility, post-IPO adjustment after the January 2025 listing, and macro pressures like interest rate sensitivity on growth stocks. Early January peaks near $2.26 rode merger momentum, but shares drifted lower amid low liquidity and earnings uncertainty.

Persistent themes included revenue ramp-up from $1 million in Q1 2025, offset by net losses of $206.9 million TTM. Institutional positioning was mixed, and edge AI competition weighed on multiples. Overall, caution prevailed until earnings refocused on 2026 guidance of $130 million revenue, underscoring trends in efficient AI infrastructure.

Discovering Trending AI Robots for Your Trading

In my research, I often turn to Tickeron’s Trending AI Robots page, which highlights top performers from its library of hundreds of algorithms trading thousands of tickers across markets. It spotlights bots excelling recently in metrics like win rate, profit factor, and drawdown, covering strategies from scalping and momentum to trend following and mean reversion in equities, forex, or crypto. With detailed backtests, live results, and customization, these offer practical insights for volatile areas like AI stocks—I've found it helpful to match bots to my portfolio needs.

What to Watch in BZAI's Outlook Moving Forward

One thing that stands out is Q1 2026 earnings, where progress toward $130 million full-year revenue guidance and adjusted EBITDA loss of -$45 million to -$50 million will be key. Watch for Q2 launches like the AI Services platform, potentially adding recurring revenue via APIs. Partnerships with Nokia and GSiL, alongside Asia-Pacific sovereign AI and defense expansions, merit close attention for deal progress. Broader factors—AI infrastructure demand, interest rates on growth valuations, and competition—remain vital. Risks involve scaling execution amid losses, funding dilution, and AI/semiconductor regulations. I'm watching this closely for signs of profitability inflection.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: BZAI

BZAI's RSI Indicator ascends from oversold territory

The RSI Indicator for BZAI moved out of oversold territory on August 26, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 13 similar instances when the indicator left oversold territory. In 11 of the 13 cases the stock moved higher. This puts the odds of a move higher at 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for BZAI just turned positive on September 02, 2026. Looking at past instances where BZAI's MACD turned positive, the stock continued to rise in 14 of 47 cases over the following month. The odds of a continued upward trend are 30%.

Following a +7.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where BZAI advanced for three days, in 72 of 124 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.

The Aroon Indicator entered an Uptrend today. In 75 of 282 cases where BZAI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 27%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 24, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BZAI as a result. In 28 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 35%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BZAI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

BZAI broke above its upper Bollinger Band on September 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.678) is normal, around the industry mean (51.456). P/E Ratio (0.000) is within average values for comparable stocks, (82.636). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.135). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.395) is also within normal values, averaging (69.875).

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. BZAI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BZAI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Salesforce (NYSE:CRM), Shopify Inc (NASDAQ:SHOP), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Datadog (NASDAQ:DDOG), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Workday (NASDAQ:WDAY), Atlassian Corp (NASDAQ:TEAM), Autodesk (NASDAQ:ADSK).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 9.9B. The market cap for tickers in the group ranges from 39 to 244.09B. SAPGF holds the highest valuation in this group at 244.09B. The lowest valued company is STIXF at 39.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was 1%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 9%. RPGL experienced the highest price growth at 166%, while WCT experienced the biggest fall at -84%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was 14%. For the same stocks of the Industry, the average monthly volume growth was 32% and the average quarterly volume growth was -4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 76
Price Growth Rating: 59
SMR Rating: 77
Profit Risk Rating: 94
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
BZAI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry PackagedSoftware

Industry
N/A
Address
4659 Golden Foothill Parkway
Phone
+1 916 347-0050
Employees
254
Web
https://www.blaize.com
Interact to see
Advertisement
In my view, JPM stands out as the largest U.S. bank by assets and market capitalization, commanding leading market shares across key segments. It holds approximately 11.1% of U.S. retail deposits, 23.6% of credit card sales volume, 8.4% of global investment banking fees, 11.8% of markets revenue, and 10% of treasury services revenue. This diversified "universal banking model" spans consumer and community banking, commercial and investment banking, and asset and wealth management, generating resilient revenue streams.
In recent sessions, WMT has held steady around $124, pulling back from February highs near $134. From what I see, this resilience stands out as the stock has outperformed broader indices year-to-date, thanks to its defensive role in groceries and essentials. Shoppers are leaning toward value options, and consistent volumes show ongoing institutional support. The premium valuation reflects confidence in Walmart's omnichannel progress and market share gains. Even with macro headwinds, I view WMT as a portfolio staple during uncertain times.
I've been following ANTX, a biopharmaceutical company based in Menlo Park, California, that develops novel small molecule therapeutics from its proprietary boron chemistry platform. The focus is on underserved areas like infectious diseases, with the lead candidate epetraborole advancing in Phase 3 trials for non-tuberculous mycobacterial (NTM) lung disease and acute melioidosis. The pipeline also includes AN2-502998 for chronic Chagas disease in preclinical stages, along with programs in oncology.
Tilly's, Inc. (TLYS) operates as a specialty retailer specializing in casual apparel, footwear, accessories, and hardgoods aimed at young men, women, boys, and girls. The company focuses on branded fashion inspired by action sports, surf, and skate culture, offering products like tops, bottoms, swimwear, backpacks, hats, and sunglasses from well-known brands such as Vans and Hurley. With approximately 223 stores in malls and lifestyle centers, complemented by e-commerce through www.tillys.com, Tilly's effectively combines physical and digital sales channels.
NKE shares are tumbling approximately 11% in premarket trading on April 1, 2026, sliding to near nine-year lows after the previous close of $52.82. The primary catalyst is Nike's weak Q4 fiscal 2026 guidance: management projected a 2%–4% revenue decline, sharply missing analyst expectations of approximately 1.9% growth.
Aemetis, Inc. (AMTX) is a renewable natural gas and renewable fuels company focused on developing and commercializing low- and negative-carbon intensity products that replace petroleum-based fuels. The company operates through segments including California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. Its core business model centers on converting agricultural waste—such as dairy manure into biogas and corn/wood waste into ethanol—into high-value biofuels like renewable natural gas (RNG), ethanol, biodiesel, and sustainable aviation fuel precursors.
Silvaco Group, Inc. (SVCO) provides technology computer-aided design (TCAD) software, electronic design automation (EDA) software, and semiconductor intellectual property (SIP) solutions. The company helps semiconductor and photonics firms design, simulate, and optimize processes from atomic-level modeling to complex system-on-chip (SoC) development. Its business centers on licensing software tools and IP blocks, along with engineering services, targeting high-growth areas like AI, power devices, automotive, foundries, and 5G/6G mobile.
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
APTV shares are tumbling approximately 14% in premarket trading on April 1, 2026, representing one of the sharpest single-session losses in the stock's recent history. The primary catalyst is Aptiv's Board of Directors formally approving the long-anticipated spin-off of its Electrical Distribution Systems (EDS) business, now named Versigent, combined with the announcement of a $1.6 billion private offering of senior notes tied to the transaction.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
RH shares are down approximately 17% in premarket trading on April 1, 2026, after closing the previous session at $139.82, with the stock indicated near $115.76 — a decline of roughly $24 per share. The primary catalyst is a significant Q4 fiscal year 2025 earnings miss, with adjusted EPS of $1.53 coming in well below the Wall Street consensus of $2.22 — a 31% negative surprise.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ORIC Pharmaceuticals shares are down approximately 21% in premarket trading on April 1, 2026, from a prior session close of approximately $12.19, placing the premarket price near $9.63. The primary catalyst is the after-market release of Phase 1b dose optimization data for rinzimetostat (ORIC-944) on March 31, alongside the selection of 400 mg once daily as the recommended Phase 3 dose for the Himalayas-1 registrational trial.
Shares of Target Hospitality Corp. (Nasdaq: TH) surged approximately 38% during Wednesday's trading session, climbing from a prior close of $9.28 to approximately $12.81. The primary catalyst is the company's announcement of a landmark multi-year lease and services agreement worth over $550 million with a top-five global hyperscaler to build and operate a data center workforce community in North Texas.
Shares of Turning Point Brands (TPB) are falling sharply intraday on April 1, 2026, shedding approximately 15% from their prior session close of roughly $87.41, placing the stock near $74.30. The primary catalyst is broad investor risk-off selling tied to mounting trade-policy uncertainty ahead of President Trump's sweeping tariff announcements scheduled for April 2 — a day the administration has branded "Liberation Day".